对Ad4BP/SF-1的DNA甲基化抑制了Cyp11a1和C2C12核细胞中的Star转录
Jumpei Fujiki1, Naoyuki Maeda2, Kosuke Yamaguchi1
1Laboratory of Veterinary Biochemistry, Department of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.
Molecular and cellular endocrinology
|August 2, 2024
概括
基因甲基化调节C2C12核细胞中的类固醇生成. 脱甲基化Ad4BP/SF-1可以调节类固醇基因Cyp11a1和StAR,影响皮质的生物合成.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 类固醇生成发生在外围组织和内分泌腺体中.
- 鼠标的C2C12神经细胞和老鼠的骨肌肉具有局部的葡萄糖皮质激素通路.
- 这些组织中缺少关键的类固醇基因表达 (Cyp11a1,StAR).
研究的目的:
- 研究DNA甲基化在调节类固醇基因中的作用.
- 检查Ad4BP/SF-1甲基化与类固醇基因表达之间的关系.
- 确定脱甲基化对C2C12核细胞中的类固醇生成的影响.
主要方法:
- 甲基化DNA免疫沉的生物信息学分析.
- 用5-aza-2-deoxycytidine (一种去甲基化剂) 治疗C2C12细胞核细胞.
- 通过敲击抑制Ad4BP/SF-1基因沉默.
- 基因表达的量化 (Ad4BP/SF-1,Cyp11a1,StAR) 和孕的水平.
主要成果:
- Cyp11a1基因体没有显著的DNA甲基化,但Ad4BP/SF-1内基增强剂具有甲基化CpG岛.
- 5-aza-2-deoxycytidine治疗以时间和剂量依赖的方式上调Ad4BP/SF-1,Cyp11a1和Star基因表达.
- 即使在去甲基化处理后,Ad4BP/SF-1敲击抑制了Cyp11a1和StAR表达和孕隆的产生.
结论:
- 对Ad4BP/SF-1的DNA甲基化可能会降低C2C12核细胞中的类固醇基因 (Cyp11a1,StAR) 的下调.
- 在这个模型中,Ad4BP/SF-1是Cyp11a1和STAR表达的关键转录因子.
- 通过DNA甲基化的表观遗传调节在局部类固醇生成中起着重要作用.
更多相关视频
11:53An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
6.6K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.5K
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
